Quest Partners LLC Spring Works Therapeutics, Inc. Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 1,004 shares of SWTX stock, worth $50,792. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,004
Previous 590
70.17%
Holding current value
$50,792
Previous $18.9 Million
91.89%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$362 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$284 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$175 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$166 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$152 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.16B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...